Free Trial

Ensysce Biosciences (ENSC) Earnings Date, Estimates & Call Transcripts

Ensysce Biosciences logo
$0.59 -0.06 (-9.20%)
(As of 11/21/2024 ET)

Ensysce Biosciences Latest Earnings Summary

Upcoming
Earnings Date
Mar. 21Estimated
Actual EPS
(Nov. 12)
$0.07 Beat By $0.37
Consensus EPS
(Nov. 12)
-$0.30

Ensysce Biosciences posted Q3 2024 earnings on November 12, 2024, reporting an EPS of $0.07, which topped analysts' consensus estimates of -$0.30 by $0.37. Quarterly revenue was reported to be $3.42 million, above analyst estimates of $0.25 million. With a trailing EPS of -$1.83, Ensysce Biosciences' earnings are expected to decrease next year, from ($0.83) to ($0.85) per share.

ENSC Upcoming Earnings

Ensysce Biosciences' next earnings date is estimated for Friday, March 21, 2025, based off prior year's reporting schedules.

Get Ensysce Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ensysce Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ENSC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENSC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ensysce Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$3.85-$0.53-$2.19
Q2 20242-$3.06-$0.38-$1.72
Q3 20242-$2.80-$0.33-$1.57
Q4 20242-$2.85-$0.28-$1.57
FY 20248-$12.56-$1.52-$7.04
Q1 20251-$1.05-$1.05-$1.05
Q2 20251-$1.09-$1.09-$1.09
Q3 20251-$1.07-$1.07-$1.07
Q4 20251-$1.08-$1.08-$1.08
FY 20254($4.29)($4.29)($4.29)

Ensysce Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/21/2025
(Estimated)
------- 
11/12/2024--$0.30$0.07+$0.37$0.07$0.25M$3.42M
8/14/2024--$0.39-$0.22+$0.17-$0.22$0.30M$0.18M
5/10/2024Q1 2024-$0.90-$0.55+$0.35-$0.55$0.40M$0.31M
3/15/2024Q4 2023-$0.86-$1.13 -$0.27-$1.13$0.53M$0.52M
11/9/2023Q3 2023-$1.06-$0.87+$0.19-$0.87$0.59M$0.44M
8/11/2023Q2 2023-$2.73-$0.98+$1.75-$0.98$0.83M$0.49M
5/15/2023Q1 2023-$13.91-$2.08+$11.83-$2.08$0.73M$0.79M
3/30/2023Q4 2022-$31.09-$18.25+$12.84-$18.25$1.81M$1.43M

Ensysce Biosciences Earnings - Frequently Asked Questions

Ensysce Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 21st, 2025 based off last year's report dates. Learn more on ENSC's earnings history.

In the previous quarter, Ensysce Biosciences (NASDAQ:ENSC) reported $0.07 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.37. Learn more on analysts' earnings estimate vs. ENSC's actual earnings.

Ensysce Biosciences (NASDAQ:ENSC) has a recorded annual revenue of $2.23 million.

Ensysce Biosciences (NASDAQ:ENSC) has a recorded net income of -$10.61 million. ENSC has generated -$1.83 earnings per share over the last four quarters.

Ensysce Biosciences's earnings are expected to decrease from ($0.83) per share to ($0.85) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:ENSC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners